Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tyro3 family-mediated cell entry of Ebola and Marburg viruses.
Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. Shimojima M, et al. Among authors: ebihara h. J Virol. 2006 Oct;80(20):10109-16. doi: 10.1128/JVI.01157-06. J Virol. 2006. PMID: 17005688 Free PMC article.
Analysis of the Function of the Lymphocytic Choriomeningitis Virus S Segment Untranslated Region on Growth Capacity In Vitro and on Virulence In Vivo.
Taniguchi S, Yoshikawa T, Shimojima M, Fukushi S, Kurosu T, Tani H, Fukuma A, Kato F, Nakayama E, Maeki T, Tajima S, Lim CK, Ebihara H, Kyuwa S, Morikawa S, Saijo M. Taniguchi S, et al. Among authors: ebihara h. Viruses. 2020 Aug 16;12(8):896. doi: 10.3390/v12080896. Viruses. 2020. PMID: 32824338 Free PMC article.
Identification of Novel Rodent-Borne Orthohantaviruses in an Endemic Area of Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka.
Muthusinghe DS, Shimizu K, Lokupathirage SMW, Wei Z, Sarathkumara YD, Fonseka GRA, Senarathne P, Koizumi N, Kawakami T, Koizumi A, Wickramasinghe C, Ebihara H, Matsuno K, Tsuda Y, Arikawa J, Gamage CD, Yoshimatsu K. Muthusinghe DS, et al. Among authors: ebihara h. Viruses. 2021 Oct 2;13(10):1984. doi: 10.3390/v13101984. Viruses. 2021. PMID: 34696414 Free PMC article.
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, Park ES, Inoue Y, Kaku Y, Tobiume M, Iwata-Yoshikawa N, Shiwa-Sudo N, Tokunaga K, Ozono S, Hemmi T, Ueno A, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Maeda K, Fukushi S, Takahashi Y, Suzuki T. Miyamoto S, et al. Among authors: ebihara h. Med. 2022 Apr 8;3(4):249-261.e4. doi: 10.1016/j.medj.2022.02.006. Epub 2022 Mar 4. Med. 2022. PMID: 35261995 Free PMC article.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Ohashi H, Hishiki T, Akazawa D, Kim KS, Woo J, Shionoya K, Tsuchimoto K, Iwanami S, Moriyama S, Kinoshita H, Yamada S, Kuroda Y, Yamamoto T, Kishida N, Watanabe S, Hasegawa H, Ebihara H, Suzuki T, Maeda K, Fukushi S, Takahashi Y, Iwami S, Watashi K. Ohashi H, et al. Among authors: ebihara h. Antiviral Res. 2022 Sep;205:105372. doi: 10.1016/j.antiviral.2022.105372. Epub 2022 Jul 4. Antiviral Res. 2022. PMID: 35798223 Free PMC article.
220 results